FDG-PET sheds light on survival in non-small cell lung cancer

04/10/2013 | MedPage Today (free registration)

Positive results on an FDG-PET scan may indicate poorer survival in patients with early-stage non-small cell lung cancer, according to findings presented at a cancer research meeting. Patients with the positive PET scan showed a median five-year survival of 67%, while survival for those with negative results was 80%. The method may help determine which patients should have adjuvant chemotherapy, researchers said.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA